The results of autopsy pathology studies suggest that Aβ and tau pathology are related to astrocyte reactivity, and as a biomarker of astrocyte reactivity, CSF levels of YKL-40 may react differently in AD-related brain processes [50]. This evidence concerns the gene MAPT and Alzheimer disease.